November 25, 2025- Premier, Inc. announced that Patient Square Capital (“Patient Square”), a dedicated health care investment firm, has completed its previously announced acquisition of Premier, valued at $2.6 billion.
With the completion of the transaction, Premier common stock ceased trading and will be delisted from Nasdaq as of November 25, 2025. Under the terms of the transaction, Premier stockholders will receive $28.25 in cash per share.
Further information about the transaction can be found in a Form 8-K filed with the U.S. Securities and Exchange Commission on November 25, 2025 by Premier.
Advisors
Goldman Sachs & Co. LLC and BofA Securities, Inc. served as financial advisors, Wachtell, Lipton, Rosen & Katz served as legal counsel, and Joele Frank served as strategic communications advisor to Premier. Cravath, Swaine & Moore LLP served as legal advisor to the Transaction Committee of the Board of Directors.
Kirkland & Ellis LLP served as legal counsel, Ropes & Gray served as health care legal counsel, Jefferies LLC and Santander served as financial advisors, and Perella Weinberg Partners LP served as debt capital markets advisor to Patient Square.